Catalysts for Novitium Pharma LLC
53 tracked
Apr 13, 2026
approval
PIMOZIDE โ FDA approval
PIMOZIDE
โ
Apr 2, 2026
approval
ACETAZOLAMIDE โ FDA approval
ACETAZOLAMIDE
โ
Feb 10, 2026
approval
FLUDROCORTISONE ACETATE โ FDA approval
Novitium Pharma LLC
โ
Feb 3, 2026
approval
ALENDRONATE SODIUM โ FDA approval
ALENDRONATE SODIUM
โ
Feb 2, 2026
approval
MIRTAZAPINE โ FDA approval
mirtazapine ODT
โ
Jan 26, 2026
approval
TAPENTADOL HYDROCHLORIDE โ FDA approval
tapentadol hydrochloride ER
โ
Jan 20, 2026
approval
SERTRALINE HYDROCHLORIDE โ FDA approval
SERTRALINE HYDROCHLORIDE
โ
Dec 22, 2025
approval
LEVORPHANOL TARTRATE โ FDA approval
LEVORPHANOL TARTRATE
โ
Dec 22, 2025
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
โ
Dec 22, 2025
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
Novitium Pharma LLC
โ
Dec 22, 2025
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
Novitium Pharma LLC
โ
Dec 16, 2025
approval
HYDROXYZINE HYDROCHLORIDE โ FDA approval
HYDROXYZINE HYDROCHLORIDE
โ
Dec 10, 2025
approval
OMEPRAZOLE AND SODIUM BICARBONATE (OMEPRAZOLE) โ FDA approval
omeprazole DR
โ
Oct 22, 2025
approval
LOFEXIDINE HYDROCHLORIDE โ FDA approval
LOFEXIDINE HYDROCHLORIDE
โ
Oct 17, 2025
approval
CLOMIPHENE CITRATE โ FDA approval
CLOMIPHENE CITRATE
โ
Oct 15, 2025
recall
GenoGenix LLC recall (Cls II)
Novitium Pharma LLC
โ
May 9, 2025
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
Novitium Pharma LLC
โ
Apr 30, 2025
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
โ
Mar 13, 2025
approval
ACETAZOLAMIDE โ FDA approval
ACETAZOLAMIDE
โ
Nov 21, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
โ
Nov 21, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
Novitium Pharma LLC
โ
Oct 31, 2024
approval
LEVORPHANOL TARTRATE โ FDA approval
LEVORPHANOL TARTRATE
โ
Oct 31, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
Novitium Pharma LLC
โ
Oct 31, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
Novitium Pharma LLC
โ
Oct 23, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
โ
Oct 9, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
Novitium Pharma LLC
โ
Jun 12, 2024
approval
LEVORPHANOL TARTRATE โ FDA approval
LEVORPHANOL TARTRATE
โ
Feb 12, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
Novitium Pharma LLC
โ
Feb 12, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
Novitium Pharma LLC
โ
Feb 12, 2024
approval
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE (ASPIRIN) โ FDA approval
Novitium Pharma LLC
โ